Bactiguard Holding AB (publ) (FRA:5JE)

Market Cap	49.23M -52.3%
Revenue (ttm)	20.84M -7.4%
Net Income	-724.81K
EPS	-0.02
Shares Out	n/a
PE Ratio	n/a
Forward PE	1,228.43
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	0
Open	1.255
Previous Close	1.230
Day's Range	1.255 - 1.255
52-Week Range	1.230 - 3.390
Beta	n/a
RSI	41.93
Earnings Date	Feb 5, 2026

About Bactiguard Holding AB

Bactiguard Holding AB (publ), a medTech company, provides infection prevention technology and solutions in orthopedics, cardiology, neurology, urology, and vascular access areas. It also operates through license partnerships with global MedTech companies that apply the technology to medical devices and sell them under own brand and co-branded. The company also has a portfolio of wound management products, such as Hydrocyn Aqua, an antimicrobial solution and gel for improved wound healing; and surgical sutures comprising non-absorbable, natural ...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 2005
• Employees: 153
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 5JE

Financial Performance

In 2025, Bactiguard Holding AB's revenue was 225.57 million, a decrease of -7.43% compared to the previous year's 243.68 million. Losses were -7.84 million, -73.69% less than in 2024.

Financial numbers in SEK